Race and Hormone Receptor–Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial
Joseph A. Sparano(Tisch Cancer Institute), Nancy E. Davidson(WinnMed), Fengmin Zhao(Dana-Farber Cancer Institute), Vered Stearns(Johns Hopkins University), Edith A. Perez(Unknown), George W. Sledge(Caris Life Sciences (United States)), Μolin Wang(Shandong University), William C. Wood(Eastern Cooperative Oncology Group), Tom Saphner(University of Wisconsin–Green Bay), Antonio C. Wolff(Johns Hopkins University), Silvana Martino(Angeles Clinic and Research Institute), Jennifer A. Ligibel(Dana-Farber Cancer Institute)
Cited by 109
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
|Annals of Oncology|2013|3.7k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k